Evidence map›Paper›PMID 10861213›Full record

ArticleThe Biochemical journal2000

Apolipoprotein E includes a binding site which is recognized by several amyloidogenic polypeptides.

M H Baumann, J Kallijärvi, H Lankinen, C Soto, M Haltia

Open access · bronzeAbstract read
In one paragraph

Article in The Biochemical journal, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

M H BaumannInstitute of Biomedicine, Protein Chemistry Education and Research Unit, P.O. Box 8, FIN-00014 University of Helsinki, Finland. Marc.Baumann@helsinki.fi
J Kallijärvi
H Lankinen
C Soto
M Haltia
University of Helsinki · FI

Funding

BIOCHEMISTRY OF LEWY BODIES AND GELSOLIN AMYLOIDR01NS030455 · NINDS · NEW YORK UNIVERSITY · PI FRANGIONE, BLAS · 1991 to 1994
–
THE BIOCHEMISTRY OF BRAIN AMYLOIDS AND PREAMYLOID LESIONSR35AG010953 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CASTANO, EDUARDO M · 1992 to 1998
–
NIA NIH HHS AG-10953NINDS NIH HHS NS-30455-04
6 · The paper itself

Abstract

Inheritance of the apolipoprotein E (apoE) epsilon 4 allele is a risk factor for late-onset Alzheimer's disease (AD). Biochemically apoE is present in AD plaques and neurofibrillary tangles of the AD brain. There is a high avidity and specific binding of apoE and the amyloid beta-peptide (A beta). In addition to AD apoE is also present in many other cerebral and systemic amyloidoses, Down's syndrome and prion diseases but the pathophysiological basis for its presence is still unknown. In the present study we have compared the interaction of apoE with A beta, the gelsolin-derived amyloid fragment AGel(183-210) and the amyloidogenic prion fragments PrP(109-122) and PrP(109-141). We show that, similar to A beta, also AGel and PrP fragments can form a complex with apoE, and that the interaction between apoE and the amyloidogenic protein fragments is mediated through the same binding site on apoE. We also show that apoE increases the thioflavin-T fluorescence of PrP and AGel and that apoE influences the content of beta-sheet conformation of these amyloidogenic fragments. Our results indicate that amyloids and amyloidogenic prion fragments share a similar structural motif, which is recognized by apoE, possibly through a single binding site, and that this motif is also responsible for the amyloidogenicity of these fragments.

Indexed as

Amino Acid MotifsAmyloid beta-PeptidesAmyloidosisApolipoproteins EBinding, CompetitiveBinding SitesBlotting, WesternCircular DichroismElectrophoresis, Polyacrylamide GelHumansKineticsPeptidesProtein BindingProtein ConformationProtein Structure, SecondarySpectrometry, FluorescenceAmyloid beta-PeptidesApolipoproteins EPeptides

Identifiers

PMID10861213
PMCPMC1221122
OpenAlexW2038701303

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.